Focus of the laboratory is to understand the coagulation-cancer interface using computational drug designing, molecular dynamic simulation; chemical synthesis of various compounds (small group inhibitors, various phospholipids, etc), molecular biology techniques and to find its involvement with signaling pathways in cancer progression. Our other interest includes signaling associated with monocyte  to macrophage differentiation.